-5%
Recodep is prescribed for the treatment of moderate to severe depression accompanied by moderate to severe anxiety. The symptoms that may respond within the first week of treatment include insomnia, feelings of guilt or worthlessness, agitation, both psychic and somatic anxiety, suicidal thoughts, and loss of appetite.
Recodep contains Amitriptyline, a tricyclic antidepressant, and Chlordiazepoxide, an anxiolytic.
- Amitriptyline works by inhibiting the reuptake of norepinephrine and serotonin in the brain, which contributes to its antidepressant effect.
- Chlordiazepoxide enhances the effect of GABA (gamma-aminobutyric acid) by increasing chloride influx through GABA receptor channels, leading to membrane hyperpolarization and resulting in sedative and anxiolytic effects.